Skip to main content
. 2021 Oct;9(20):1595. doi: 10.21037/atm-21-4660

Table 1. Patient characteristics.

Variables No frequent defecation group (n=205), n (%) Frequent defecation group (n=59), n (%) P
Age, median 1.000
   ≤70 years 172 (83.90) 50 (84.75)
   >70 years 33 (16.10) 9 (15.25)
Gender 0.210
   Male 141 (68.78) 35 (59.32)
   Female 64 (31.22) 24 (40.68)
BMI 0.053
   ≤18.5 kg/m2 20 (9.76) 1 (1.69)
   >18.5 kg/m2 185 (90.24) 58 (98.31)
Hypertension 0.165
   Yes 38 (18.54) 6 (10.17)
   No 167 (81.46) 53 (89.83)
Diabetes 0.815
   Yes 22 (10.73) 7 (11.86)
   No 183 (89.27) 52 (88.14)
Neoadjuvant therapy 1.000
   Yes 81 (39.51) 23 (38.98)
   No 124 (60.49) 36 (61.02)
Adjuvant chemotherapy 0.550
   Yes 124 (60.49) 33 (55.93)
   No 81 (39.51) 26 (44.07)
Distance from anal verge 0.883
   ≤5 cm 95 (46.34) 28 (47.46)
   >5 cm 110 (53.66) 31 (52.54)
Pathological T stage 0.619
   T0 18 (8.78) 7 (11.86)
   T1 15 (7.32) 4 (6.78)
   T2 49 (23.90) 19 (32.20)
   T3 119 (58.05) 28 (47.46)
   T4 4 (1.95) 1 (1.69)
Pathological N stage 0.686
   N0 151 (73.66) 45 (76.27)
   N+ 38 (18.54) 10 (16.95)
Metastasis 0.495
   M0 196 (95.61) 55 (93.22)
   M1 9 (4.39) 4 (6.78)
Presacral abscess 0.618
   Yes 4 (1.95) 2 (3.39)
   No 201 (98.05) 57 (96.61)
Anastomotic inflammation 0.641
   Yes 70 (34.15) 18 (30.51)
   No 135 (65.85) 41 (69.49)
Proctitis 0.029
   Yes 9 (4.39) 8 (13.56)
   No 196 (95.61) 51 (86.44)
Enteritis 0.846
   Yes 35 (17.07) 11 (18.64)
   No 170 (82.93) 48 (81.36)
Anastomotic stenosis 0.016
   Yes 17 (8.29) 12 (20.34)
   No 188 (91.71) 47 (79.66)
Duration of stoma (days) 1.000
   ≤120 75 (36.59) 21 (35.59)
   >120 130 (63.41) 38 (64.41)